Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1882

1.

Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM.

Luo Y, Guo X, Yan H, Fang D, Zeng G, Zhou J, Jiang L.

Appl Microbiol Biotechnol. 2015 Mar 31. [Epub ahead of print]

PMID:
25822571
2.

Animal models for some important RNA viruses of public health concern in SEARO countries: Viral hemorrhagic fever.

Badole SL, Yadav PD, Patil DR, Mourya DT.

J Vector Borne Dis. 2015 Jan-Mar;52(1):1-10.

PMID:
25815861
3.

The Influence of Diet on the Use of Near-Infrared Spectroscopy to Determine the Age of Female Aedes aegypti Mosquitoes.

Liebman K, Swamidoss I, Vizcaino L, Lenhart A, Dowell F, Wirtz R.

Am J Trop Med Hyg. 2015 Mar 23. pii: 14-0790. [Epub ahead of print]

PMID:
25802436
4.

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults.

Kirkpatrick BD, Durbin AP, Pierce KK, Carmolli MP, Tibery CM, Grier PL, Hynes N, Diehl SA, Elwood D, Jarvis AP, Sabundayo BP, Lyon CE, Larsson CJ, Jo M, Lovchik JM, Luke CJ, Walsh MC, Fraser EA, Subbarao K, Whitehead SS.

J Infect Dis. 2015 Mar 22. pii: jiv082. [Epub ahead of print]

PMID:
25801652
5.

A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate.

McArthur MA, Edelman R.

J Infect Dis. 2015 Mar 22. pii: jiv086. [Epub ahead of print] No abstract available.

PMID:
25801651
6.

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.

Suzarte E, Gil L, Valdés I, Marcos E, Lazo L, Izquierdo A, García A, López L, Álvarez M, Pérez Y, Castro J, Romero Y, Guzmán MG, Guillén G, Hermida L.

Int Immunol. 2015 Mar 20. pii: dxv011. [Epub ahead of print]

PMID:
25795768
7.

The role of residence times in two-patch dengue transmission dynamics and optimal strategies.

Lee S, Castillo-Chavez C.

J Theor Biol. 2015 Mar 17. pii: S0022-5193(15)00108-3. doi: 10.1016/j.jtbi.2015.03.005. [Epub ahead of print]

PMID:
25791283
8.

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-naïve Adults: A Randomized, Double-blind Phase I Clinical Trial.

George SL, Wong MA, Dube TJ, Boroughs KL, Stovall JL, Luy BE, Haller AA, Osorio JE, Eggemeyer LM, Irby-Moore S, Frey SE, Huang CY, Stinchcomb DT.

J Infect Dis. 2015 Mar 19. pii: jiv179. [Epub ahead of print]

PMID:
25791116
9.

Dengue virus infection with highly-neutralizing levels of cross-reactive antibodies cause acute lethal small intestinal pathology without high level of viremia in mice.

Watanabe S, Chan KW, Wang J, Rivino L, Lok SM, Vasudevan SG.

J Virol. 2015 Mar 18. pii: JVI.00216-15. [Epub ahead of print]

PMID:
25787279
10.

Economic and disease burden of dengue in Mexico.

Undurraga EA, Betancourt-Cravioto M, Ramos-Castañeda J, Martínez-Vega R, Méndez-Galván J, Gubler DJ, Guzmán MG, Halstead SB, Harris E, Kuri-Morales P, Tapia-Conyer R, Shepard DS.

PLoS Negl Trop Dis. 2015 Mar 18;9(3):e0003547. doi: 10.1371/journal.pntd.0003547. eCollection 2015 Mar.

11.

[Dengue and chikungunya acquired during travel in the tropics].

van Aart CJ, Braks MA, Hautvast JL, de Mast Q, Tostmann A.

Ned Tijdschr Geneeskd. 2015;159(0):A8032. Dutch.

PMID:
25784059
12.

Mechanistic basis for morphological damage induced by essential oil from Brazilian pepper tree, Schinus terebinthifolia, on larvae of Stegomyia aegypti, the dengue vector.

Pratti DL, Ramos AC, Scherer R, Cruz ZM, Silva AG.

Parasit Vectors. 2015 Dec;8(1):746. doi: 10.1186/s13071-015-0746-0. Epub 2015 Mar 1.

13.

Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development.

Amat-Ur-Rasool H, Saghir A, Idrees M.

PLoS One. 2015 Mar 16;10(3):e0119854. doi: 10.1371/journal.pone.0119854. eCollection 2015.

14.

Dengue on islands: a Bayesian approach to understanding the global ecology of dengue viruses.

Feldstein LR, Brownstein JS, Brady OJ, Hay SI, Johansson MA.

Trans R Soc Trop Med Hyg. 2015 Mar 13. pii: trv012. [Epub ahead of print]

PMID:
25771261
15.

Immunogenicity of a candidate DNA vaccine based on the prM/E genes of a dengue type 2 virus Cosmopolitan genotype.

Putri DH, Sudiro TM, Yunita R, Jaya UA, Dewi BE, Sjatha F, Konishi E, Hotta H, Sudarmono P.

Jpn J Infect Dis. 2015 Mar 13. [Epub ahead of print]

PMID:
25766602
Free Article
16.

Dengue: a global threat.

Thisyakorn U, Thisyakorn C.

J Med Assoc Thai. 2015 Jan;98 Suppl 1:S118-22.

PMID:
25764623
17.

Dengue Viral Evolution Under a Host-Targeted Antiviral.

Plummer E, Buck MD, Sanchez M, Greenbaum JA, Turner J, Grewal R, Klose B, Sampath A, Warfield KL, Peters B, Ramstedt U, Shresta S.

J Virol. 2015 Mar 11. pii: JVI.00028-15. [Epub ahead of print]

PMID:
25762732
18.

Development of Flagellin: Envelope (E) Fusion Dengue Vaccines: Immunogenicity and Efficacy in Mice and Monkeys.

Liu G, Song L, Beasley DW, Putnak R, Parent J, Misczak J, Li H, Reiserova L, Liu X, Tian H, Liu W, Labonte D, Duan L, Kim Y, Travalent L, Wigington D, Weaver B, Tussey L.

Clin Vaccine Immunol. 2015 Mar 11. pii: CVI.00770-14. [Epub ahead of print]

PMID:
25761459
19.

The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.

Merani S, Chen W, Elahi S.

Rev Med Virol. 2015 Mar 11. doi: 10.1002/rmv.1832. [Epub ahead of print]

PMID:
25760439
20.

Vaccines, our shared responsibility.

Pagliusi S, Jain R, Suri RK; DCVMN Executive Committee Group.

Vaccine. 2015 Mar 4. pii: S0264-410X(15)00265-0. doi: 10.1016/j.vaccine.2015.02.065. [Epub ahead of print]

PMID:
25749248
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk